MP58-04 A RANDOMIZED DOUBLE BLINDED PLACEBO CONTROLLED CROSSOVER PILOT TRIAL BETWEEN ANASTROZOLE AND CLOMIPHENE TO EVALUATE IMPROVEMENT IN HYPOGONADAL SYMPTOMS AND ERECTILE FUNCTION

2019 
INTRODUCTION AND OBJECTIVES:The use of selective estrogen receptor modifiers (SERM) and aromatase inhibitors (AI) have been used for decades for the treatment of secondary hypogonadism. While both ...
    • Correction
    • Source
    • Cite
    • Save
    • Machine Reading By IdeaReader
    0
    References
    0
    Citations
    NaN
    KQI
    []